4//SEC Filing
Rock Edwin 4
Accession 0001209191-22-057314
CIK 0001253689other
Filed
Nov 15, 7:00 PM ET
Accepted
Nov 16, 4:26 PM ET
Size
6.9 KB
Accession
0001209191-22-057314
Insider Transaction Report
Form 4
Rock Edwin
Chief Medical Officer
Transactions
- Purchase
Common Stock
2022-11-15$1.66/sh+100,000$166,000→ 200,000 total - Purchase
Common Stock
2022-11-14$1.43/sh+100,000$143,000→ 100,000 total
Footnotes (2)
- [F1]The Reporting Person purchased the securities on the open market at purchase prices ranging from $1.31 to $1.55 per share, with a weighted average purchase price of $1.43 per share. The Reporting Person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each separate price.
- [F2]The Reporting Person purchased the securities on the open market at purchase prices ranging from $1.52 to $1.75 per share, with a weighted average purchase price of $1.66 per share. The Reporting Person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each separate price.
Documents
Issuer
GLYCOMIMETICS INC
CIK 0001253689
Entity typeother
Related Parties
1- filerCIK 0001945417
Filing Metadata
- Form type
- 4
- Filed
- Nov 15, 7:00 PM ET
- Accepted
- Nov 16, 4:26 PM ET
- Size
- 6.9 KB